CHEO Research Institute Research Programs

Molecular Biomedicine

Message from Program Director, Dr. Martin Holcik

Molecular Biomedicine program represents an exciting and dynamic group of scientists who share common interests in advancing the health of our children through research. Within the Molecular Biomedicine program, the Apoptosis Research Centre and the Infectious Disease and Vaccine Research Centre, take advantage of advanced biochemistry, molecular biology, molecular genetics, and proteomic technologies to identify new targets and therapeutic approaches for the treatment of various disorders including diabetes, neuromuscular disorders, infectious diseases, and cancer. A strong “bench-to-bedside” or translational value to the experimental approaches has been and will remain a strong element of our research. In addition to a superb research environment, the Molecular Biomedicine program provides an excellent training setting for students at all levels and postdoctoral fellows, as most of the principle investigators are cross-appointed to basic science departments at the University of Ottawa. The research groups are well supported by high levels of funding from government sources, charitable organizations and the private sector. I am thrilled to be involved with this talented group of dedicated researchers and look forward to both the challenges and the achievements that the future will bring.